InflaRx (IFRX) Interest Coverage Ratio (2016 - 2026)
InflaRx (IFRX) posted Interest Coverage Ratio of 476.41 for Q1 2026, down 67.04% sequentially from 1445.37 in Q4 2025, and down 84.65% YoY from 3103.11 in Q1 2025.
InflaRx (IFRX) Interest Coverage Ratio (2016 - 2026) Analysis & Trends
InflaRx has reported Interest Coverage Ratio for 11 years, with the latest figure at 476.41 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 84.65% year-over-year to 476.41 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3223.25 (down 13699.07% YoY) and the FY2025 annual result came in at 0.0, up 51.13% from the prior year.
- Interest Coverage Ratio retreated to 476.41 in Q1 2026 per IFRX's latest filing, from 1445.37 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 3103.11 in Q1 2025 and troughed at 3850.37 in Q2 2025.
- A 5-year average of 604.28 and a median of 660.0 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio slumped 1526.41% in 2023, then jumped 140676646727929.6% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 1382.16 in 2022, then plunged by 129.8% to 411.82 in 2023, then soared by 381.93% to 1161.04 in 2024, then climbed by 24.49% to 1445.37 in 2025, then slumped by 67.04% to 476.41 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 476.41, 1445.37, and 660.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 1.42 |
| 10 | InflaRx | 141.98 Mn | -42.27 Mn | 2.74 Bn | 481.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 476.41 |
| Dec 31, 2025 | 1,445.37 |
| Sep 30, 2025 | 660.00 |
| Jun 30, 2025 | -3,850.37 |
| Mar 31, 2025 | 3,103.11 |
| Dec 31, 2024 | 1,161.04 |
| Sep 30, 2024 | 3,052.47 |
| Jun 30, 2024 | -1,763.25 |
| Mar 31, 2024 | 2,696.18 |
| Dec 31, 2023 | -411.82 |
| Sep 30, 2023 | 2,277.08 |
| Jun 30, 2023 | -1,950.94 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 1,382.16 |
| Sep 30, 2022 | 1,255.55 |
| Jun 30, 2022 | 136.77 |
| Mar 31, 2022 | 602.99 |
| Dec 31, 2021 | 1,762.85 |
| Sep 30, 2021 | 1,336.48 |
| Jun 30, 2021 | 4,584.32 |